Evidence map›Paper›PMID 42358812›Full record

ArticleOncology research2026

PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer.

Zhengzheng Li, Haitong Xie, Yujuan Chen, Qiuyan Li, Xing Yuan, Xinyue Dai, Jie Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhengzheng LiDepartment of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
Haitong XieDepartment of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
Yujuan ChenDepartment of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
Qiuyan LiBreast Center, West China Tianfu Hospital, Sichuan University, Chengdu, China.
Xing YuanDepartment of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xinyue DaiBreast Center, West China Tianfu Hospital, Sichuan University, Chengdu, China.
Jie ChenDepartment of General Surgery, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epithelial-Mesenchymal TransitionPhosphoglycerate KinaseTriple Negative Breast NeoplasmsUbiquitin-Protein LigasesAnimalsCell Line, TumorCell MovementFemaleGene Expression Regulation, NeoplasticHumansLung NeoplasmsMiceNeoplasm MetastasisProteolysisUbiquitinationPGK1 protein, humanPhosphoglycerate KinaseUbiquitin-Protein Ligasesepithelial-to-mesenchymal transitionmetastasisParkinson disease protein 2 (PARK2)phosphoglycerate kinase 1 (PGK1)proteasomal degradationTriple-negative breast cancer (TNBC)

Identifiers

PMID42358812
PMCPMC13292048

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.